ABOUT THE ACTUATOR
The first of its kind, The Actuator is a deeply collaborative national program that gives promising early-stage medical technology companies an accelerated pathway to $2.7 million of funding, capitalising on Australia’s strengths in medical research, healthcare, clinical trials and advanced manufacturing.
We’re about real markets, real needs, real healthcare and real experts. We surround our portfolio with people and tools that are doing things that really matter. We have a deep medtech focus—commercialising those genuinely radical new technologies like bionics, devices, implants, instrumentation and AI that will create a step-change in our health systems and in our economies.
This initiative has received funding through the MTPConnect Project Fund Program—a dollar-for-dollar matched program investing in big, bold ideas to improve the productivity, competitiveness and innovative capacity of Australia’s medical technology, biotechnology and pharmaceutical sector. MTPConnect is supported by the Australian Government Industry Growth Centres Initiative. Learn more at mtpconnect.org.au.
The Actuator is a spin-out of STC Australia—one of Australia’s longest-lived advanced technology incubators.
The Actuator is made possible through collaboration across our ecosystem partners who have come together to create Australia’s economic and healthcare future.
Our special thanks go to our partners and sponsors: MTP Connect, the Federal Government, STC Australia, the Victorian State Government, Artesian, EY, Johnson & Johnson, Medtronic, Cook Medical, Baker Heart and Diabetes Institute, Burnet Institute, Macquarie University, Swinburne University, Griffith Hack, MiniFAB, Planet Innovation, Procept, Hydrix, Wave Digital, Design+Industry, Ingenuity Electronics Design, IDE Group, Blue Curve, Brandwood Biomedical, Truly Deeply, Innermaven, EsicHub, Dialectica Group, Melbourne Angels, Invetech, Mobius Medical, Foundersuite, Australian Healthcare Solutions, Paul L Clark And Associates, Vestech, FAB9, F2F Communications, BioMelbourne Network, Cogentum, Global Data, GrantReady, Tenfold Business Coaching, K&L Gates, Science in Public and Seedly.
HOW TO APPLY
Application rounds will open every six months.
Applicants may submit an Expression of Interest for eligibility or submit a full application.
EOI’s for the inaugural intake close 16 November 2017, with applications open until 30 November 2017 for participation in the program from 1 February 2018 – 1 May 2019.
Applications must be by an Australian company incorporated within the previous five years, be based on intellectual property (i.e. patents), be on a regulated pathway (e.g. TGA) and hardware-based (i.e. diagnostic, bionics, device, instrumentation, digital health and services).
Visit our application form.
Information sessions will be held on 9 November in Adelaide, Brisbane, Melbourne and Sydney. Check the website for details.